//
sign in
Profile
by @danabra.mov
Profile
by @dansshadow.bsky.social
Profile
by @jimpick.com
AviHandle
by @danabra.mov
AviHandle
by @dansshadow.bsky.social
AviHandle
by @katherine.computer
EventsList
by @katherine.computer
ProfileHeader
by @dansshadow.bsky.social
ProfileHeader
by @danabra.mov
ProfileMedia
by @danabra.mov
ProfilePlays
by @danabra.mov
ProfilePosts
by @danabra.mov
ProfilePosts
by @dansshadow.bsky.social
ProfileReplies
by @danabra.mov
Record
by @atsui.org
Skircle
by @danabra.mov
StreamPlacePlaylist
by @katherine.computer
+ new component
ProfilePosts









Loading...
Healthcare is changing. As chronic diseases place growing pressure on patients, healthcare systems, and society, new approaches are needed to improve how we predict, prevent, and personalize care. Better healthcare starts with better disease understanding. A new conversation begins June 17 🎙️
PrecisionLife & Ovation are bringing precision medicine to GLP-1s - with new genetic markers predicting response and tests launching in 2026. This creates a significant opportunity to improve outcomes for patients, payors, providers, and pharma. Learn more here: precisionlife.com/news-and-eve...
Presenting new research at #EEC2026 Our talk on genomic signatures of female #infertility in #endometriosis & related conditions was selected for the best abstracts session. 24 Apr | 11:30 Krystyna Taylor presenting
Rowan Gardner (@rowanbio.bsky.social) will present new DecodeME analysis at #IIMEC18: 'Expanding Mechanistic Insights in ME - Analysis of DecodeME population and what’s next' New insights into ME/CFS and long COVID biology, patient stratification, and future research directions. #MECFS #LongCOVID
Our new paper out today in Nature Comms, led by the amazing @profmarkfaghy.bsky.social Current status and future perspectives on the mechanistic And pathophysiological understanding of Long Covid www.nature.com/articles/s43...
What might these findings mean? precisionlife.com/glp1
what might these findings mean? precisionlife.com/glp1
There's still time to sign up for our second workshop for our PRIME research project! 📅 When? Friday 24 April, 2-5pm GMT 📍 Online 🔗 Register to attend: us02web.zoom.us/webinar/regi... 👉 Read the full programme: www.actionforme.org.uk/prime-worksh...
1d
1mo
1mo
3mo
3mo
1mo
22d
1mo
Faghy et al., review the current literature on Long COVID pathophysiology, linking immune dysregulation, viral persistence, and vascular injury to enduring symptoms. They highlight evidence to guide f...
Current status and future perspectives on the mechanistic and pathophysiological understanding of long COVID - Communications Medicine
www.nature.com
Very excited to see how fast these insighgts emerge with top quality data from @precisionlife.bsky.social partner Ovation. precisionlife.com/news-and-eve... #genomics #PMWC #precisionmedicine 🧬🖥️
3mo
PrecisionLife
PrecisionLife
PrecisionLife
PrecisionLife
Binita Kane
Wear pink Tues Jan 13th at #JPM26 to recognize impact of women leaders & allies in bio. Wear a pink shirt, tie or socks if you don’t own a pink blazer. We had an incredible turnout at inaugural event at #JPM25 w/ pink visible throughout the streets of SF. Join group pic at 4pm #BiotechCEOSisterhood
Action for ME
Rowan Gardner
Rowan Gardner
6mo
Rowan Gardner
PrecisionLife and Ovation are developing a test to predict GLP-1 drug response, enabling precision prescribing and sustainable access to these therapies.
precisionlife.com
Predicting GLP-1 response: foundation for precision prescribing
PrecisionLife and Ovation identify genetic biomarkers to predict GLP-1 response and expand their partnership to develop precision prescribing tools.
precisionlife.com
PrecisionLife and Ovation identify first genetic biomarkers to quantitatively predict GLP-1 efficacy response
Daphne Zohar